<HashMap><database>GEO</database><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type> Other</gds_type><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313597</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>High throughput sequencing of B and T cells in checkpoint inhibitor treated patients</name><description>This is a prospective longitudinal study designed to identify biomarkers predictive of the onset of irAEs associated with ICI therapy and determine whether these biomarkers are further related to treatment efficacy. We obtained serial blood samples in patients who will be receiving anti-PD-1/PD-L1 either as a single agent or in combination with other therapy.</description><dates><publication>2026/05/01</publication></dates><accession>GSE313597</accession><cross_references><GSM>GSM9370870</GSM><GSM>GSM9370871</GSM><GSM>GSM9370872</GSM><GSM>GSM9370862</GSM><GSM>GSM9370863</GSM><GSM>GSM9370864</GSM><GSM>GSM9370865</GSM><GSM>GSM9370866</GSM><GSM>GSM9370867</GSM><GSM>GSM9370868</GSM><GSM>GSM9370869</GSM><GSM>GSM9370880</GSM><GSM>GSM9370881</GSM><GSM>GSM9370860</GSM><GSM>GSM9370882</GSM><GSM>GSM9370861</GSM><GSM>GSM9370883</GSM><GSM>GSM9370873</GSM><GSM>GSM9370874</GSM><GSM>GSM9370875</GSM><GSM>GSM9370876</GSM><GSM>GSM9370877</GSM><GSM>GSM9370878</GSM><GSM>GSM9370857</GSM><GSM>GSM9370879</GSM><GSM>GSM9370858</GSM><GSM>GSM9370859</GSM><GPL>30173</GPL><GSE>313597</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>